Pfizer Limited v Medimpex Jamaica Ltd, etal

Case Number: 
C.L. 2002/P040
Date of Delivery: 
04.07.2005

IN THE SUPREME COURT OF JUDICATURE OF JAMAICA

CLAIM NO. C.L. 2002lP040

BETWEEN PFIZER LIMITED CLAIMANTIRESPONDENT

A N D MEDIMPEX JAMAICA 1 ST DEFEND ANTIAPPLICANT

LIMITED

A N D NMF PHARMECUTICALS 2 N ~ ~ LIMITED

AND LASCO DISTRIBUTORS 3RD DEFEhIDANTIAPPLICANT

LIMITED

Miss Hilary Phillips Q.C. and Mr. Kevin Williams

instructed by Grant Stewart Phillips for ClaimantIRespondent.

Miss Dorothy Lightbourne and Mr. Ian Robins

instructed by Tenn, Russell, Chin-Sang, Hamilton and Ramsay for 1''

DefendantIApplicant.

Mr. R. N. A. Henriques Q.C. and Mr. Vincent Chen instructed by Chen, Green and Co.

for 3rd DefendantlApplicant.

Application for stay of iniunction pending appeal

Heard: 17'~2, 3rdJ une and 41h July 2005

BROOKS, J.

On March 29, 2005 Mrs. N. E. McIntosh, J. ordered that the defendants to this

claim be restrained from conducting any dealings with any product containing the

Besylate Salt of Ainlodipine until the trial of the action.

Specific restrictions were also placed against Medimpex Jamaica Limited

(Medimpex) and Lasco Distributors Limited (Lasco) respectively, in relation to products

ltnown as "Normodipine" and "Las Amlodipine", again until the trial of the action. The

order was made at the instance of Pfizer Limited (Pfizer) which claims that these

particular products were in breach of Pfizer's rights in a patented product.

Covid-19

Emergency Matters

Emergency Matters

Matrimonial Proceedings

Customer Service

customer complaints image

Strategic Plan

Strategic Plan for the Jamaican Judiciary 2019-2023